CRISPR-Cas9 Gene Editing of Human Embryos: A Look at the ScienceApril 28, 2015Unless you were on Mars or in the middle of a Netflix binge, you couldn’t have missed the paper that has been hitting the headlines all over the world this week – the first example of the genetic modification of human embryos. The study led by Junjiu Huang (Sun Yat-sen University, Guangzhou) used CRISPR-Cas9 gene […]
CRISPR Goes Back to its Roots to Fight HIVApril 14, 2015All the cool techniques people are developing with CRISPR-Cas9 are great and all, but sometimes a repurposed natural genetic system just has to go back to its roots. If CRISPR was originally a virus defense system in bacteria, why not forget about all this genome engineering whatnot for a minute and just use it to […]
CRISPR Gets Creative with Histone AcetylationApril 9, 2015There’s been a lot of firsts in the world of genome editing happening lately, from its application in human embryonic stem cells, the identification of a smaller more versatile Cas9, to its upgrade to efficiently using homology-directed repair. Now CRISPR-Cas9 is getting its feet wet with epigenome editing thanks to the clever folks in the Gersbach lab […]
Slimmer Cas9 is Better Able to Squeeze into CellsApril 7, 2015We’ve already seen how CRISPR-Cas9 is making the headlines with its utility in human embryonic stem cell editing, but now it’s getting a makeover to make it even more attractive for use in humans. Current CRISPR-Cas9 genome editing technology is faced by two translational limitations. The first is targeting, where PAM sequences and sgRNA design […]
DNMT1 Loss is Lethal in Human But Not Mouse Embryonic Stem CellsApril 2, 2015Mouse models have been great to science, they’ve given insight into humans in ways simply not possible in humans. However, while there are striking similarities in the epigenetics of mice and men, there are also undoubtedly some fundamental differences. Now, a team from the Broad Institute of MIT and Harvard consisting of the labs of Alexander Meissner, J. Keith Joung, and John […]
Boosting CRISPR’s Editing EffectivenessMarch 31, 2015Unless you’ve been hiding under a rock you’ll know that CRISPR-Cas has been in the forefront of precise genome editing since its discovery in 1987 by Atsuo Nakata. However, as a technique it is not without shortcomings; while it has achieved a great deal of efficiency in the non-homologous end-joining (NHEJ) pathway, its ability to achieve […]
Cas9: The Ultimate Gene Driving MachineMarch 30, 2015Add one more to all the amazing things CRISPR can do: it is also the ultimate driving machine. Provided, of course, that you are a gene, and that your destination is any chromosome where you do not currently reside. Gene Drives Spread by Overwriting Alleles A gene drive is when a gene on one chromosome […]
iPSCs and CRISPR the Dynamic Duo of Regenerative MedicineMarch 23, 2015Laurel and Hardy, Peanut Butter and Jelly, Batman and Robin – can we now add iPSCs (induced pluripotent stem cells) and CRISPR to the list of famous duos? Linzhao Cheng (John Hopkins) certainly thinks so, and in a recently study his group have demonstrated how this combination of technologies may lead to an effective cell treatment […]
Webinar: An Engineered Synergistic CRISPR/Cas9 Activator Complex for Genome-wide Transcriptional ControlMarch 4, 2015Presenter: Silvana Konermann, Graduate Student in Dr Feng Zhang’s Lab at Massachusetts Institute of Technology Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. The ease and scalability of the CRISPR-Cas9 system potentially enables systematic, genome-scale perturbation, but the magnitude of transcriptional up-regulation achieved by the first generation of Cas9 transcriptional […]
Express Yourself with Light-activatable CRISPR-Cas9February 26, 2015Guess what? It seems that blue light has a lot more to offer than just helping with your winter time blues. It could also be just what your transcriptional activation system needs. Synthetic biology has a lot to offer omics beyond genome editing and recent work from multiple groups is putting Cas9 in a different spotlight. CRISPR/Cas9 […]